Skip to main content
SpringerLink
Log in

Expression of High Mobility GroupA2 is Associated with Poor Survival in Hepatocellular Carcinoma

  • Research
  • Published:
Pathology & Oncology Research

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Srivatanakul P, Sriplung H, Deerasamee S (2004) Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev 5:118–125

    PubMed  Google Scholar 

  2. Mann CD, Neal CP, Garcea G et al (2007) Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer 43:979–992

    Article  PubMed  CAS  Google Scholar 

  3. Reeves R, Beckerbauer L (2001) HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta 1519:13–29

    Article  PubMed  CAS  Google Scholar 

  4. Fusco A, Fedele M (2007) Roles of HMGA proteins in cancer. Nat Rev Cancer 7:899–910

    Article  PubMed  CAS  Google Scholar 

  5. Cleynen I, Van de Ven WJ (2008) The HMGA proteins: a myriad of functions. Int J Oncol 32:289–305

    PubMed  CAS  Google Scholar 

  6. Chiappetta G, Avantaggiato V, Visconti R et al (1996) High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13:2439–2446

    PubMed  CAS  Google Scholar 

  7. Rogalla P, Drechsler K, Frey G et al (1996) HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 149:775–779

    PubMed  CAS  Google Scholar 

  8. Ashar HR, Fejzo MS, Tkachenko A et al (1995) Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57–65

    Article  PubMed  CAS  Google Scholar 

  9. Mine N, Kurose K, Nagai H et al (2001) Gene fusion involving HMGIC is a frequent aberration in uterine leiomyomas. J Hum Genet 46:408–412

    Article  PubMed  CAS  Google Scholar 

  10. Kazmierczak B, Meyer-Bolte K, Tran KH et al (1999) A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas. Gene Chromosome Canc 26:125–133

    Article  CAS  Google Scholar 

  11. Rogalla P, Drechsler K, Kazmierczak B et al (1997) Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade. Mol Carcinog 19:153–156

    Article  PubMed  CAS  Google Scholar 

  12. Sarhadi VK, Wikman H, Salmenkivi K et al (2006) Increased expression of high mobility group A proteins in lung cancer. J Pathol 209:206–212

    Article  PubMed  CAS  Google Scholar 

  13. Meyer B, Loeschke S, Schultze A et al (2007) HMGA2 overexpression in non-small cell lung cancer. Mol Carcinog 46:503–511

    Article  PubMed  CAS  Google Scholar 

  14. Abe N, Watanabe T, Suzuki Y et al (2003) An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue. Br J Cancer 89:2104–2109

    Article  PubMed  CAS  Google Scholar 

  15. Belge G, Meyer A, Klemke M et al (2008) Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias. Gene Chromosome Canc 47:56–63

    Article  CAS  Google Scholar 

  16. Motoyama K, Inoue H, Nakamura Y et al (2008) Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res 14:2334–2340

    Article  PubMed  CAS  Google Scholar 

  17. Livak KJ, Schmittquen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Method 25:402–408

    Article  CAS  Google Scholar 

  18. Miyazawa J, Mitoro A, Kawashiri S et al (2004) Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res 64:2024–2029

    Article  PubMed  CAS  Google Scholar 

  19. Park S-M, Shell S, Radjabi AR et al (2007) Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6:2585–2590

    Article  PubMed  CAS  Google Scholar 

  20. Hristov AC, Cope L, Reyes MD et al (2009) HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma. Mod Pathol 22:43–49

    Article  PubMed  CAS  Google Scholar 

  21. Vallone D, Battista S, Pierantoni GM et al (1997) Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J 16:5310–5321

    Article  PubMed  CAS  Google Scholar 

  22. Fedele M et al (2006) HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 9:459–471

    Article  PubMed  CAS  Google Scholar 

  23. Thuault S, Valcourt U, Petersen M et al (2006) Transforming growth factor employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 174:175–183

    Article  PubMed  CAS  Google Scholar 

  24. Wang X, Liu X, Li AY et al (2011) Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers. Clin Cancer Res 17:2570–2580

    Article  PubMed  CAS  Google Scholar 

  25. Langelotz C, Schmid P, Jakob C et al (2003) Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer. Br J Cancer 88:1406–1410

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful to Dr. Xinyin Li for his comments. We also thank the patients who participated in this study.

Author information

Authors and Affiliations

  1. Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China

    Lielin Wu, Zhiming Wang & Wei Jiang

  2. Department of Respiratory, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China

    Rongli Lu

Authors
  1. Lielin Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhiming Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rongli Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wei Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhiming Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, L., Wang, Z., Lu, R. et al. Expression of High Mobility GroupA2 is Associated with Poor Survival in Hepatocellular Carcinoma. Pathol. Oncol. Res. 18, 983–987 (2012). https://doi.org/10.1007/s12253-012-9514-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-012-9514-z

Keywords

Search

Navigation